Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema Navai

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
European Urology Focus|July 30, 2017
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle InvasionMichael J Metcalfe, James E Ferguson, Roger Li, et al.
Surgical Innovation|March 21, 2018
Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical CystectomyJanet Baack Kukreja, Qiuling Shi, Courtney M Chang, et al.
BJU International|November 19, 2020
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-GuérinNathan A Brooks, Andrea Kokorovic, Lianchen Xiao, et al.
The Journal of Urology|June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical CystectomyPatrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
NPJ Digital Medicine|June 2, 2022
Aligning mission to digital health strategy in academic medical centersAdam B Cohen, Lisa Stump, Harlan M Krumholz, et al.
The Journal of Urology|August 10, 2021
Reply by AuthorsPatrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology|November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center ExperienceAkshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Molecular Cancer Research : MCR|March 4, 2020
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder CancerSharada Mokkapati, Sima P Porten, Vikram M Narayan, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
European Urology Focus|July 30, 2017
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle InvasionMichael J Metcalfe, James E Ferguson, Roger Li, et al.
Surgical Innovation|March 21, 2018
Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical CystectomyJanet Baack Kukreja, Qiuling Shi, Courtney M Chang, et al.
BJU International|November 19, 2020
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-GuérinNathan A Brooks, Andrea Kokorovic, Lianchen Xiao, et al.
The Journal of Urology|June 29, 2021
Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical CystectomyPatrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
NPJ Digital Medicine|June 2, 2022
Aligning mission to digital health strategy in academic medical centersAdam B Cohen, Lisa Stump, Harlan M Krumholz, et al.
The Journal of Urology|August 10, 2021
Reply by AuthorsPatrick J Hensley, Kelly K Bree, Matthew T Campbell, et al.
The Journal of Urology|November 3, 2023
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center ExperienceAkshay Sood, Jan K Rudzinski, Craig V Labbate, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Molecular Cancer Research : MCR|March 4, 2020
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder CancerSharada Mokkapati, Sima P Porten, Vikram M Narayan, et al.
Pageof 11